Trial Profile
A Phase 3, International, Multicenter, Open Label, Dual-Injection, Echocardiographic Imaging and Safety Study of AI-700 in Patients With Suspected Ischemic Heart Disease Undergoing Single-Photon Emission Computed Tomography
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Acronyms RAMP 1
- Sponsors Acusphere
- 05 Jun 2014 New trial record